Aigen Investment Management’s Transmedics TMDX Stock Holding History

Aigen Investment Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Buy	3,821 +1,627	+74%	+$138K	0.07%	364
2026 Q1	$218K	Buy	+2,194	New	+$286K	0.06%	412
2025 Q4	–	Sell	-3,658	Closed	-$410K	–	976
2025 Q3	$410K	Buy	+3,658	New	+$428K	0.06%	451
2025 Q1	–	Sell	-4,000	Closed	-$249K	–	1032
2024 Q4	$249K	Buy	4,000 +670	+20%	+$62.4K	0.04%	536
2024 Q3	$523K	Buy	+3,330	New	+$513K	0.1%	309
2024 Q1	–	Sell	-12,377	Closed	-$977K	–	1013
2023 Q4	$977K	Sell	12,377 -1,866	-13%	-$113K	0.17%	159
2023 Q3	$780K	Buy	+14,243	New	+$1.03M	0.15%	225
2023 Q1	–	Sell	-3,439	Closed	-$212K	–	832
2022 Q4	$212K	Buy	+3,439	New	+$183K	0.03%	442

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Aigen Investment Management's TMDX Position: Q2 2026 in Review

Aigen Investment Management increased its Transmedics (TMDX) stake by 74% in Q2 2026, buying an estimated $138K and bringing the position to 3,821 shares worth $254K. The position accounts for 0.07% of the portfolio, ranked #364.

Aigen Investment Management first reported a position in TMDX in Q4 2022 and has held it in 8 quarters since. The position peaked at $977K in Q4 2023. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Aigen Investment Management held 3,821 shares of Transmedics worth $254K as of Q2 2026.
Aigen Investment Management bought 1,627 Transmedics shares in Q2 2026, an estimated $138K.
Transmedics made up 0.07% of Aigen Investment Management's portfolio in Q2 2026, its #364 holding.
Aigen Investment Management first reported a position in Transmedics in Q4 2022 and has held it in 8 quarters since.
Aigen Investment Management's Transmedics position peaked at $977K in Q4 2023.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.